Randomized phase III study of FOLFOX plus bevacizumab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2616888
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: FOLFOX plus bevacizumab
FOLFIRI plus bevacizumab
Primary outcome(s): Progression free survival
Study Design: Parallel Randomized
创建时间：
2008-09-15
